Metagenomi Therapeutics Inc. (MGX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Metagenomi Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$0.82
+2.71% today
Market cap
$30M
Overall quality
—
Kronos AI 30-day
—
Metagenomi Therapeutics Inc. (MGX) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $30M. It trades at $0.82, up 2.71% today. 3 analysts' average target of $6.00 implies +631.7% from today's price.
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $6.00 |
| Low – high | $5.00 – $7.00 |
| Analysts | 3 |
| Upside to average | +631.7% |
Kronos AI 30-day forecast
No forecast for this listing.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.